1,2,3,4-tetrahydroisoquinoline has been researched along with Drug Withdrawal Symptoms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, N; Bansal, S; Kumar, M; Rehni, AK; Singh, I; Singh, N | 1 |
| Frolov, BS; Guzikov, BM; Spivak, LI; Sytinskiĭ, IA | 1 |
| Armando, I; Clow, A; Glover, V; Sandler, M | 1 |
1 review(s) available for 1,2,3,4-tetrahydroisoquinoline and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
[Modern concepts of the pathogenesis of alcoholism].
Topics: Alcoholism; Animals; Brain; Cyclic AMP; Cyclic GMP; Drug Tolerance; gamma-Aminobutyric Acid; Humans; Isoquinolines; Rats; Receptors, Cholinergic; Receptors, Opioid; Substance Withdrawal Syndrome; Tetrahydroisoquinolines | 1982 |
2 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Topics: Acetates; Animals; Cyclopropanes; Female; Leukotriene Antagonists; Leukotriene D4; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain Measurement; Pain Threshold; Quinolines; Signal Transduction; Substance Withdrawal Syndrome; Sulfides; Tetrahydroisoquinolines | 2008 |
Pictet-Spengler condensation products, stress and alcoholism: some clinical overtones.
Topics: Alcoholism; Animals; Carbolines; Chemical Phenomena; Chemistry; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Levodopa; Monoamine Oxidase Inhibitors; Papaverine; Rats; Salsoline Alkaloids; Stress, Physiological; Substance Withdrawal Syndrome; Tetrahydroisoquinolines; Tetrahydropapaveroline | 1982 |